Company intelligence / Profile preview

Oliver Press Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Oliver Press Partners is a New York-based investment management firm and hedge fund that specializes in value-oriented and activist investing within the healthcare and life sciences sectors. Founded by Augustus K. Oliver and Clifford Press, the firm is known for taking significant positions in undervalued biotechnology and pharmaceutical companies to drive strategic changes or operational improvements. They frequently engage in corporate governance matters, including seeking board representation to unlock shareholder value. The firm leverages deep industry expertise to manage a concentrated portfolio of healthcare-related assets and has been involved in high-profile restructurings of various medical entities.

Industry: Investors

Beyond the preview

Go deeper on Oliver Press Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oliver Press Partners.

Explore the full profile